COVID-19 Vaccines, Boosters And The Renaissance In Vaccine Technology
Short Wave
NPR
4.7 β’ 6.6K Ratings
ποΈ 22 June 2021
β±οΈ 11 minutes
ποΈ Recording | iTunes | RSS
π§ΎοΈ Download transcript
Summary
Questions? Existential dread? Optimism? We'd love to hear it β write us at shortwave@npr.org.
See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
NPR Privacy Policy
Transcript
Click on a timestamp to play from that location
| 0:00.0 | You're listening to Shortwave from NPR. |
| 0:04.6 | Hi, everyone. |
| 0:06.6 | I'm Ritu Chatterjee in the host chair for Emily Kwong for the next few weeks. |
| 0:11.0 | And today we're back with our frequent Tuesday guest, Health correspondent Alison Aubrey |
| 0:15.6 | for the latest in COVID news. |
| 0:17.4 | Hi, Alison. |
| 0:18.4 | Hey, Ritu, great to be here. |
| 0:20.0 | Great to have you. |
| 0:21.0 | And what do you have for us today? |
| 0:23.0 | Well, the country is inching closer to reaching this goal set by President Biden of vaccinating |
| 0:28.1 | 70% of adults with at least one dose by July 4th in dependent state. |
| 0:33.6 | That's not even two weeks away. |
| 0:35.4 | But some states lag behind. |
| 0:37.5 | And while the three vaccines authorized in the US are very effective, it's possible that |
| 0:42.4 | booster shots may be needed to maintain protection. |
| 0:46.2 | And Ritu, let's also talk about mRNA technology. |
| 0:49.8 | We've all heard that term now, right? |
| 0:51.8 | Totally. |
| 0:52.8 | We've got a huge underway to make mRNA vaccines for everything from flu to HIV possibly to |
| 0:59.5 | even cancers. |
| 1:03.6 | So today on the show, a COVID news roundup with NPR Health correspondent Alison Aubrey, |
| 1:09.6 | we're listening to shortwave, the daily science podcast from NPR. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from NPR, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of NPR and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright Β© Tapesearch 2026.

